On Monday 26th of October Corvus trades -1.13 percent lower
Corvus stock dips 1.13% as investors weigh its $885M market cap, 52‑week highs at $26.95, and next‑phase cancer drug pipeline.
- CORVUS PHARMACEUTICALS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read